| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Interest expense, debt, excluding amortization | - | - | - | 471,356 |
| Amortization of debt discount | - | - | - | 3,774 |
| Total other income (expense) | 1,049,325 | 142,262 | -234,223 | -435,359 |
| Net income (loss) | 752,365 | -308,027 | -655,969 | -1,607,122 |
| Series d preferred dividends | 7,500 | 7,500 | 15,000 | 7,500 |
| Net income (loss) attributable to common stockholders | 744,865 | -315,527 | -670,969 | -1,614,622 |
| Net (loss) income per share attributable to common stockholders basic | 0.24 | -0.1 | -0.22 | -0.52 |
| Net (loss) income per share attributable to common stockholders diluted | 0.24 | -0.1 | -0.22 | -0.52 |
| Weighted average common shares outstanding basic | 3,067,059 | 3,067,059 | 3,067,059 | 3,067,059 |
| Weighted average common shares outstanding diluted | 3,067,059 | 3,067,059 | 3,067,059 | 3,067,059 |
SELECTIS HEALTH, INC. (GBCS)
SELECTIS HEALTH, INC. (GBCS)